Arcturus Therapeutics Holdings Inc.
ARCT· Nasdaq
Released Nov 9, 2022, after the close
10-Q filed Nov 9, 2022, 40 days after period end · 0000950170-22-023969
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $13.37M | $2.44M | $2.33M | $3.32M |
| Net Income | -$35.27M | -$54.08M | -$21.00M | -$7.43M |
| EPS Diluted |
Arcturus Therapeutics Holdings Inc. · CIK 1768224 · Engraved from SEC EDGAR
| -$1.33 |
| -$2.05 |
| -$0.92 |
| -$0.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.